InvestorsHub Logo
icon url

fogbottom

08/12/08 1:42 PM

#13648 RE: DewDiligence #13646

Dew,

Thank you for the transcript. Everything I try has sound; except GTCB conference calls.

icon url

xrymd

08/12/08 2:34 PM

#13651 RE: DewDiligence #13646


Heparin-resistance occurs in up to 15% to 20% of CPB operations and we estimate the fully developed market in the US to be approximately $150 million.


FWIW: I asked several cardiac surgeons and cardiac anesthesiologists about heparin resistance in CABG. It does not seem to be as common clinically as in the literature. One surgeon said he remembers only 4 or 5 cases in 20 years of practice.
icon url

pharm

08/12/08 2:37 PM

#13653 RE: DewDiligence #13646

Thanks a lot Dew.
icon url

rveach

08/12/08 3:30 PM

#13655 RE: DewDiligence #13646

Hey Dew, thank you for this posting:-) rveach
icon url

gym gravity

08/12/08 3:54 PM

#13657 RE: DewDiligence #13646

here are the private equity geniuses that back Ovation:

GTCR

GTC recombinant?

http://www.gtcr.com/investment_approach/index.asp?